Danielle M. Pastor

Also affiliated with Johns Hopkins University, National Cancer Institute, Center for Cancer Research, Sidney Kimmel Comprehensive Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.”.

Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.093

N/A

0.241DataRank · unranked

4 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Phase II evaluation of combination immunotherapy with CV301, N-803, bintrafusp alfa, and M9241 in patients with advanced small bowel and colorectal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.116

N/A

0.241DataRank · unranked

4 citations

Jason M. Redman, Charalampos S. Floudas, Elizabeth Lamping, Deneise C Francis, Lisa M. Cordes +5 more

Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy

JAAD Case Reports(2024)10.1016/j.jdcr.2024.09.029

N/A

0.208DataRank · unranked

3 citations

Vincent Poon, Patrick Hallaert, Deneise C Francis, Danielle M. Pastor, Leslie Castelo-Soccio +3 more

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

Frontiers in Oncology(2024)10.3389/fonc.2024.1376622

N/A

0.208DataRank · unranked

3 citations

Kellsye P. Fabian, Michelle R. Padget, Yvette Robbins, Joshua T. Kowalczyk, Wiem Lassoued +7 more

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report

Frontiers in Oncology(2023)10.3389/fonc.2023.1126476

N/A

0.104DataRank · unranked

1 citations

Danielle M. Pastor, Fatima Karzai, Amy Hankin, Barış Türkbey, Lisa M. Cordes +5 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps6116

N/A

0DataRank · unranked

1 citations

Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, Jenn Marte +7 more

Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors

International Journal of Molecular Sciences(2025)10.3390/ijms26094394

N/A

0DataRank · unranked

21 citations

James L. Gulley, Danielle M. Pastor, Joy Awosika

Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report

Frontiers in Oncology(2020)10.3389/fonc.2020.603248

N/A

0DataRank · unranked

4 citations

Katherine Lee-Wisdom, Andrew E. Arai, Arlene Sirajuddin, Douglas R. Rosing, Borys Korchin +3 more

Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations

Cancers(2025)10.3390/cancers17243981

N/A

0DataRank · unranked

4 citations

Ilhan Birsenogul, Ashley Bowen, J Doyle, Stephen E. Pupkin, Joaquín Villar +5 more

Immunology of Lynch Syndrome

Current Oncology Reports(2021)10.1007/s11912-021-01085-z

N/A

0DataRank · unranked

36 citations

Jeffrey Schlom, Danielle M. Pastor

Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2518

N/A

0DataRank · unranked

11 citations

Charalampos S. Floudas, Danielle M. Pastor, Michell Manu, Elizabeth Lamping, Deneise C Francis +11 more

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.127

N/A

0DataRank · unranked

4 citations

Ravi A. Madan, Nicole J. Toney, Renee N. Donahue, Margaret E. Gatti‐Mays, Julius Strauss +12 more

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17033

N/A

0DataRank · unranked

3 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more